SCHEMBL8092570

SCHEMBL8092570

COC(=O)c1ccc2c(c1)C(C)(c1ccc3c(c1)C(C)(C)CCC3(C)C)CS2

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.51
RARB P10826 5/20 0.48
RARG P13631 5/20 0.48
RARA P10276 4/20 0.48
CYP26A1 O43174 6/20 0.47
RXRA P19793 12/20 0.46
CYP26B1 Q9NR63 3/20 0.46
RXRB P28702 8/20 0.43
RXRG P48443 5/20 0.42
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7801896 0.87 RXRA (0.57) CYP3A4RARBRARGRARACYP26A1
SCHEMBL2788640 0.81 CYP3A4 (0.70) CYP3A4RARBRARGRARACYP26A1
SCHEMBL6734636 0.77 CYP3A4 (0.51) CYP3A4RARBRARGRARACYP26A1
SCHEMBL7793997 0.76 CYP26B1 (0.42) CYP3A4RARBRARGRARACYP26A1
SCHEMBL7799679 0.76 CYP26B1 (0.42) CYP3A4RARBRARGRARACYP26A1
SCHEMBL6729936 0.76 CYP3A4 (0.49) CYP3A4RARBRARGRARACYP26A1
SCHEMBL7799675 0.76 CYP26B1 (0.61) CYP3A4RARBRARGRARACYP26A1
SCHEMBL7799676 0.76 CYP26B1 (0.61) CYP3A4RARBRARGRARACYP26A1
SCHEMBL8707418 0.75 RXRA (0.72) CYP3A4RARBRARGRARACYP26A1
SCHEMBL8708782 0.75 RXRA (0.74) CYP3A4RARBRARGRARACYP26A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6030952-A AS HUMAN AND VETERINARY MEDICINE, PARTICULARLY IN THE TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR AND OPHTHALMOLOGIC CONDITIONS, AND IN COSMETIC COMPOSITIONS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIOUES GALDERMA (FR) 2000-02-29 US disclosed